NewsInvestors Respond Positively To Senior Appointment At Under-Fire UK...

Investors Respond Positively To Senior Appointment At Under-Fire UK CBD Firm

-

CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as its new head of sales and marketing. 

The CBD retailer, which has seen its share price drop by nearly 80% since January 2021, has brought in the former Anheuser-Busch InBev and Juul Labs senior sales manager as its new Chief Commercial Officer (CCO). 

Mr Sandore will be tasked with boosting sales across the US, UK and Europe, after Chill reported revenues of $561,330 in the three months to September 30 2021, its most recently published financial figures. 

While the company announced the launch of new product ranges last month, including CBD Gummies and flavoured tinctures to the UK and US, alongside a new marketing partnership with US Major Arena Soccer League (MASL), Mr Sandore still has a number of issues to contend with in the coming year. 

Retail Heavyweights

Among these is the ongoing roll out of Chill’s CBD tobacco substitute to tens of thousands of retail stores across the US, as per a distribution deal signed with Asian America Trade Association (AATAC) in 2020, which Chill says has been ‘influenced’ by ongoing supply chain delays. 

However, investors believe Mr Sandore is well placed to oversee this process, having spent more than three years as a sales director at US electronic cigarette giant Juul, where he handled the accounts for retail heavyweights 7-Eleven, Circle K and QuikTrip. 

“Chill Brands is positioning itself as an early leader in two of the fastest growing consumer brand segments — CBD and tobacco alternative products,” Mr Sandore said

“Today’s adult customer is looking for alternative products and the Chill brand is positioned to offer a variety of alternatives for any occasions those adult customers gravitate to. I want to personally thank Antonio Russo and Trevor Taylor for this incredible opportunity.”

Investor Approval

His appointment has been generally well received by investors, many of whom have been critical of the brand’s lack of financial transparency and communication over the past year, in part leading to its poor stock performance. 

One investor said the appointment showed that their ‘voices were heard’. 

Since yesterday’s announcement, Chill’s stock has increased from around 16p to 18.5p, hitting highs of 20p in yesterday’s trading. 

While the increase will be a welcome positive for investors, Chill’s stock is still less than a third of the 63p price it held in January 2021.   

Latest news

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Seizure Of 32 Tons Of Cannabis In Spain Was Actually Hemp

BETWEEN telephone calls, Francisco Carbó continues finalising contracts for E-Canna, the hemp processing company he owns based in Valencia,...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing...

You might also likeRELATED
Recommended to you